Dear Herman Animals that are sick tend not to move around a lot. One can imagine that this limits the tendency for animal viruses and other animal pathogens to become more and more virulent, because the very virulent strains won't spread as fast. And (importantly) when the most virulent strains finally arrive at some particular location, they will find that their potential hosts are already immune*.
Since plants don't move around, I have always wondered why plant pathogens don't increase in virulence until they wipe out their hosts, especially when you bear in mind that plants don't have complex immune systems. Could these multiple genes be a way to avoid being wiped out by disease? Ie if the plant gets sick, it just switches on a batch of "reserve" genes**. Is that possible? Thx, Patrick * This is a pet theory of mine: https://oldwivesandvirologists.blog **Or maybe the expression of these genes is random - two genetically identical individuals growing side-by-side might express different batches of genes on a random basis. Again, this might be mainly about disease prevention. On Fri, Sep 20, 2019 at 8:51 AM <herman.schreu...@sanofi.com> wrote: > Dear John, > > Plants cannot walk away to a more favorable spot. They remain stuck where > they germinate, e.g. whether the place is sunny, shady, wet, dry, fertile, > poor etc. So plants compensate by having a lot of genes available to be > able to adapt to the particular spot where happen to be. And indeed, plants > have usually more genes then animals! > > Best, > > Herman > > > > *Von:* CCP4 bulletin board [mailto:CCP4BB@JISCMAIL.AC.UK] *Im Auftrag von > *John R Helliwell > *Gesendet:* Freitag, 20. September 2019 09:19 > *An:* CCP4BB@JISCMAIL.AC.UK > *Betreff:* [EXTERNAL] Re: [ccp4bb] AW: [ccp4bb] challenges in structural > biology > > > > *EXTERNAL : *Real sender is owner-ccp...@jiscmail.ac.uk > > > > Dear Martin, > > Many thanks for these details of the size of the human genome over the > decades and also the news of your most interesting upcoming review. I shall > read it with great interest. > > Incidentally is the over 40000 genes for the rice genome number correct? > This number caught my eye as being interesting how the rice genome is more > complicated than our genome. > > Best wishes, > > John > > Emeritus Professor John R Helliwell DSc > > > > > > > > > On 19 Sep 2019, at 08:35, Kollmar, Martin <m...@nmr.mpibpc.mpg.de> wrote: > > Dear John, > > the „100,000 human genes“ is a long-standing myth broad forward by the > initiators of the U.S. human genome sequencing projects in 1990. This large > number completely contradicted all genetics and mutation data since the 1940 > th, but the sequencing community (genome, cDNA, EST) didn’t read even the > standard text books. Thus, the “30,000” genes published with the two human > genome papers in 2001 are not “surprisingly low” but just in accordance > with the predictions and the data since the 1940th. The gene number went > down to about 23,000 already in 2004, and the current numbers (depending on > database) range around 20,000 human protein-coding genes. The myth of the > large numbers is only propagated by those who profit from larger numbers > (e.g. bigger grants, papers in higher IF journals, big consortia). > > > > I have written a review about the current state (and history) of the human > protein-coding genes, which will appear online in BioEssays soon and > finally in the November issue (will be open access). In this review there > will be some (hopefully) useful plots showing the gene numbers since the > 1940th and a detailed review of all the numbers and their experimental > basis (most were actually just extrapolations from small-scale data). > > > > Please excuse this kind of self-advertisement, but it is really more than > time to move this myth out of science literature and communication. > > > > Best regards, > > Martin > > > > Priv. Doz. Dr. Martin Kollmar > > > > Group Systems Biology of Motor Proteins > > Department NMR-based Structural Biology > > Max-Planck-Institute for Biophysical Chemistry > > Am Fassberg 11 > > 37077 Goettingen > > Deutschland > > > > www.motorprotein.de > <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.motorprotein.de_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=IWuNyBzheAGJ761iddc78L4lz7sB21cKQTrawbV4j0M&e=> > (Homepage) > > www.cymobase.org > <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.cymobase.org_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=fMYqMfsorSLNspHq5-Wx_WDkChCYsDr9NEXwrGsKvpo&e=> > (Database of Cytoskeletal and Motor Proteins) > > www.diark.org > <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.diark.org_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=QB0-HJUz9wLSC-Xd5_Bj6Gnhx70AaYoxkD8kIu7Ub6A&e=> > (diArk - a resource for eukaryotic genome research) > > www.webscipio.org > <https://urldefense.proofpoint.com/v2/url?u=http-3A__www.webscipio.org_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=sy5FDRUX22Q-6XcBo-X_-tgZenKZRLf9N__I8x3pnBo&e=> > (Scipio - eukaryotic gene identification) > > > > *Von:* CCP4 bulletin board <CCP4BB@JISCMAIL.AC.UK> *Im Auftrag von *John > R Helliwell > *Gesendet:* Donnerstag, 19. September 2019 08:51 > *An:* CCP4BB@JISCMAIL.AC.UK > *Betreff:* Re: [ccp4bb] challenges in structural biology > > > > Dear James, > > Well, 100,000 genes used to be the estimate of the size of the human > genome. > > (eg see > https://physicsworld.com/a/protein-crystallography-the-human-genome-in-3-d/ > <https://urldefense.proofpoint.com/v2/url?u=https-3A__physicsworld.com_a_protein-2Dcrystallography-2Dthe-2Dhuman-2Dgenome-2Din-2D3-2Dd_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=Au_C7wioq-2-qa1kL026q6V6n88YzwYRsi2fGz6xjpg&e=> > ) > > It seems it has got easier, albeit still gargantuan, at ~30,000 genes to > be expressed into proteins. > > > > Meanwhile funding agencies also look out for Big Ideas:- > > > https://epsrc.ukri.org/research/ourportfolio/epsrcbigideas/?utm_source=Twitter&utm_medium=social&utm_campaign=SocialSignIn > <https://urldefense.proofpoint.com/v2/url?u=https-3A__epsrc.ukri.org_research_ourportfolio_epsrcbigideas_-3Futm-5Fsource-3DTwitter-26utm-5Fmedium-3Dsocial-26utm-5Fcampaign-3DSocialSignIn&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=TMvBW-JMC-G_OW0woSqqukhb03utq-y672taYl38T9Y&e=> > > and even helpfully spell out the difference between a Big Idea and a Grand > Challenge! > > Maybe an “Open Door for funding” for us all? > > > > Today also the repertoire of methods capable of resolving in 3D protein > structures has expanded further with the splendid development of cryoEM. > > > > To define challenges in terms of projects, as Max Perutz taught us > (“Haemoglobin the Molecular Lung”) avoids methods looking for problems. > > > > Also a final thought, how we organise ourselves in different areas of the > World varies according to our cultural traditions. So the Big Project is > neutral to politics and can accommodate all contributions however so > arrived at. > > > > “What shall we do with it?” > > As Darwin taught us, first make your Collection...... > > > > Greetings! > > John > > > > Emeritus Professor John R Helliwell DSc > > > https://www.crcpress.com/The-Whats-of-a-Scientific-Life/Helliwell/p/book/9780367233020 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.crcpress.com_The-2DWhats-2Dof-2Da-2DScientific-2DLife_Helliwell_p_book_9780367233020&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=xJvbX5e1byn0_V91NpWaz5pd5GEYg9BKtNQKHCkMeKM&e=> > > > > > > > On 18 Sep 2019, at 22:15, James Holton <jmhol...@lbl.gov> wrote: > > Thank you John, an excellent choice as always. Here is your trillion > dollars! Now, what are you going to do with it? > > Do you think simply scaling up current technology could reach this goal? > More screens, more combinations, more compute cycles? Remember, if you > want the "genome/proteome" you need all of it, including all those > super-cool human membrane proteins we gave up on because they were too > hard. > > I think we all have at least one of those projects in our past. What was > the show-stopper in the end? Did they just not grow crystals? Poor > diffraction? Weird diffraction? Twinned? Won't phase? Won't refine to a > decent R factor? Annoying reviewer? Did you try cryoEM? NMR? and did they > not work either? > > I think a key question for all of us is: what new capability would make > you decide to go back and pick up your old favorite project again? Without > your structure, the genome is incomplete. > > -James Holton > MAD Scientist > > On 9/16/2019 12:24 AM, John R Helliwell wrote: > > Dear James, > > Here you go, a “grand challenge” suggestion to consider for funding from > the “James Holton Foundation for structural biology research”:- > > “The human genome/proteome in 3-D” > > Greetings, > > John > > Emeritus Professor John R Helliwell DSc > > > > > > > > > On 14 Sep 2019, at 02:39, James Holton <jmhol...@lbl.gov> wrote: > > > I would like to thank everyone who took the time to respond to my question > that started this thread. It is really good for me to get a sense of the > community perspective. Some debates were predictable, others not. Many > ideas I agree with, some not so much. All were thought-provoking. I think > this is going to be a really good GRC! > > Something I did not expect to distill from all the responses is that the > dominant challenge in structural biology is financial. The most common > strategy suggested for addressing this challenge was torpedoing other > scientists in similar fields, perhaps expecting to benefit from the > flotsam. Historically, this strategy is often counterproductive and at > best inefficient. The good news is there is a lot of room for improvement. > In reality, we are all on the same ship, and the people in our funding > agencies fighting to get us what we need can be much more effective when > armed with positive ideas and clear plans. That is a better strategy for > overcoming this challenge. > > To this end, my first GRC session title is going to be: > > "If I had a trillion dollars for structural biology" > > I think we can all agree that science in general is vastly under-funded > relative to the impact it has on the human condition. For example, I > estimate the value of a general cure for cancer to be at least a trillion > dollars. This is based on the lives claimed every year, multiplied by how > much one person would gladly pay after being diagnosed (amortized over the > rest of their much longer life). This is only ~1% of the Gross World > Product, a real bargain if we can come up with a plan that will actually > work. > > Now, obviously not all cancer research is structural biology, but not all > structural biology is cancer research either. Let us suppose for a moment > that you (yes, I'm talking to YOU), were given a trillion-dollar budget to > do your science. After buying all the tools and hiring all the people you > wanted: would that solve all of your problems? I expect not. The > intellectual and technical challenges that remain are what I believe > science is really all about, and the 2020 Diffraction Methods GRC will > focus on the ones facing structural biology. > > My goals here are twofold: > 1) I believe it would be healthy for this field if we all spent a little > time "thinking big" > 2) I want to remove financial anxiety from the discussion, both here and > at the GRC. > > I ask for one restraint: please confine the discussion to structural > biology. I understand it is difficult to think about the trillion-dollar > level without involving politics, but the CCP4 Bulletin Board is not a > political discussion forum, and neither is the GRC. Assume all the other > worthy causes in the world are given their own ample budgets. This trillion > is yours, and you have to spend it on structural biology. If you can't > think of anything, think harder. > > To get you started, a few things that could be done for under a trillion > dollars: > 1) re-do all the protein crystallization in the PDB, 500 times (saving all > information) > 2) buy Google and Facebook, get their AI teams to do machine learning and > structure prediction for us > 3) hire every "biological scientist" in the world, and give each $1M to > work on your projects > 4) re-do the NASA Apollo program three times > 5) build 1000 XFELs and 100,000 Titan microscopes (yes, that's "and") > 6) solve the phase problem by brute force. (zettaflops-scale computing at > $0.03/gflop) > 7) build half a dozen terapixel detectors (ask Colin Nave what those can > do) > 8) fund every NIH grant submitted in the last 5 years. Not just the > awarded ones, all of them. > 9) X-prize style competitions for landmark achievements, such as > predicting crystallization outcomes, or finding a universal way to stop > protein from denaturing on the air-water interface. > > This is not a to-do list, but rather an attempt to convey the scale of > what can be done. Oh, and you have a month or so to think about it. The > meeting is July 26-31 2020, but my speaker list is due Oct 15. > > Now, of course, at the GRC I will not actually have billion-dollar prizes > to pass around, but I do want to set our sights on those lofty goals, and > then work on the bridge we will need to get there. > > So, when I say "challenge" I mean more than something we all agree is > hard. Those would make for very short talks. I am after something more > like a benchmark. Useful challenges should have certain properties. They > should be: > a) possible, because something that doesn't work no matter what you do is > no fun. > b) hard, because something that is too easy is also not very interesting > c) realistic, as in relevant to a real-world problem we all agree is > important > d) accessible, as in reasonable download sizes and/or affordable reagents > e) fast, because it if takes forever to try it nobody will have time to > participate > f) measurable, as in having a clear and broadly acceptable "score" > g) adjustable, as in the level of "difficulty" can be selected > continuously between "easy" and "impossible". > > This last one is important because it is at the transition point between > success and failure that teaches us the most about what can be improved. > > Some challenges that already exist are: > anomalous phasing from weak signals > https://bl831.als.lbl.gov/~jamesh/challenge/anom/ > <https://urldefense.proofpoint.com/v2/url?u=https-3A__bl831.als.lbl.gov_-7Ejamesh_challenge_anom_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=0IJQWNeTwpNxj1WNhXurnD-UrpV5RQ1cHpgke0pHcsw&e=> > anomalous phasing from twinned data > https://bl831.als.lbl.gov/~jamesh/challenge/twin/ > <https://urldefense.proofpoint.com/v2/url?u=https-3A__bl831.als.lbl.gov_-7Ejamesh_challenge_twin_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=dDs_r6utWD9Sh6VhJST1OsWgNZVKRubPS2-H6PH_Ed0&e=> > merging highly incomplete data with an indexing ambiguity > https://bl831.als.lbl.gov/~jamesh/challenge/microfocus/ > <https://urldefense.proofpoint.com/v2/url?u=https-3A__bl831.als.lbl.gov_-7Ejamesh_challenge_microfocus_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=PcG8DXXeww_NLMoXqNEb_esUbiARpm2gZ6daHSSVqMI&e=> > extracting motions from diffuse scatter data > https://bl831.als.lbl.gov/~jamesh/challenge/diffuse/ > <https://urldefense.proofpoint.com/v2/url?u=https-3A__bl831.als.lbl.gov_-7Ejamesh_challenge_diffuse_&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=Q6TAvbSKkAAxEcS8GMgtDkfFTUAQdm6oiK_xQGRohOw&e=> > Coming soon: > dial-a-resolution model building challenge > XFEL data processing reference set > > -James Holton > MAD Scientist > > On 7/25/2019 10:07 AM, Keller, Jacob wrote: > > >>It would seem to me that an important issue is also: do get all > information out of our diffraction data? By integrating the Bragg peaks we > usually neglect the diffuse scattering that could potentially contain > additional (dynamic) structural information. This can be cloudy diffuse > scattering hidden in the background but also diffuse streaks that contain > information on packing disorder and reveals intrinsic interactions in the > crystal. > > > > Along these lines, and taking a page from you also, how about > “crystallographic model refinement as image-faking?” Metrics of the > goodness of a particular refinement could simply be some measure of the > correlation between predicted vs. measured images. I have seen some of this > done with diffuse scattering, but why not with the whole thing, including > intensity and shape of Bragg peaks, solvent rings, etc? Maybe instead of > doing the multiple steps of (indexing, integration, scaling, solving…) all > of this could be refined as one? Processing parameters like moscaicity > [sic] etc would now be part of the final model…? > > > > JPK > > > > > > > > > Loes Kroon-Batenburg > > On 07/15/19 21:44, Holton, James M wrote: > > Hello folks, > > > > I have the distinct honor of chairing the next Gordon Research > > Conference on Diffraction Methods in Structural Biology (July 26-31 > > 2020). This meeting will focus on the biggest challenges currently > > faced by structural biologists, and I mean actual real-world > > challenges. As much as possible, these challenges will take the form of > > friendly competitions with defined parameters, data, a scoring system, > > and "winners", to be established along with other unpublished results > > only at the meeting, as is tradition at GRCs. > > > > But what are the principle challenges in biological structure > > determination today? I of course have my own ideas, but I feel like I'm > > forgetting something. Obvious choices are: > > 1) getting crystals to diffract better > > 2) building models into low-resolution maps (after failing at #1) > > 3) telling if a ligand is really there or not > > 4) the phase problem (dealing with weak signal, twinning and > > pseudotranslation) > > 5) what does "resolution" really mean? > > 6) why are macromolecular R factors so much higher than small-molecule ones? > > 7) what is the best way to process serial crystallography data? > > 8) how should one deal with non-isomorphism in multi-crystal methods? > > 9) what is the "structure" of something that won't sit still? > > > > What am I missing? Is industry facing different problems than > > academics? Are there specific challenges facing electron-based > > techniques? If so, could the combined strength of all the world's > > methods developers solve them? I'm interested in hearing the voice of > > this community. On or off-list is fine. > > > > -James Holton > > MAD Scientist > > > > > > ######################################################################## > > > > To unsubscribe from the CCP4BB list, click the following link: > > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.jiscmail.ac.uk_cgi-2Dbin_webadmin-3FSUBED1-3DCCP4BB-26A-3D1&d=DwMFAw&c=LU6cRtx0xgB8s29tIz9Olw&r=eLCg9eJ4Rs_LnxfUWsp7FSxhIEcZYmTSU4Uyq1bRYPI&m=j60Req0Ctc22ORJ8Tr5oxj6jiKrZs6a6a3qScsFKgfg&s=nvFe-NBmWDef18CvLm-0QKC6gd9nDyAZxKO5eEZ7t1I&e=> > > > > > > > -- > > > > __________________________________________ > > > > Dr. Loes Kroon-Batenburg > > Dept. of Crystal and Structural Chemistry > > Bijvoet Center for Biomolecular Research > > Utrecht University > > Padualaan 8, 3584 CH Utrecht > > The Netherlands > > > > E-mail : l.m.j.kroon-batenb...@uu.nl > > phone : +31-30-2532865 > > fax : +31-30-2533940 > > __________________________________________ > > > ------------------------------ > > To unsubscribe from the CCP4BB list, click the following link: > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.jiscmail.ac.uk_cgi-2Dbin_webadmin-3FSUBED1-3DCCP4BB-26A-3D1&d=DwMFAw&c=LU6cRtx0xgB8s29tIz9Olw&r=eLCg9eJ4Rs_LnxfUWsp7FSxhIEcZYmTSU4Uyq1bRYPI&m=j60Req0Ctc22ORJ8Tr5oxj6jiKrZs6a6a3qScsFKgfg&s=nvFe-NBmWDef18CvLm-0QKC6gd9nDyAZxKO5eEZ7t1I&e=> > > > ------------------------------ > > To unsubscribe from the CCP4BB list, click the following link: > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.jiscmail.ac.uk_cgi-2Dbin_webadmin-3FSUBED1-3DCCP4BB-26A-3D1&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=9UgmXd4v3TIc9n4xsYN8gLYWH_H3YoFK6twdNr3syaA&e=> > > > ------------------------------ > > To unsubscribe from the CCP4BB list, click the following link: > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.jiscmail.ac.uk_cgi-2Dbin_webadmin-3FSUBED1-3DCCP4BB-26A-3D1&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=9UgmXd4v3TIc9n4xsYN8gLYWH_H3YoFK6twdNr3syaA&e=> > > > > > ------------------------------ > > To unsubscribe from the CCP4BB list, click the following link: > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.jiscmail.ac.uk_cgi-2Dbin_webadmin-3FSUBED1-3DCCP4BB-26A-3D1&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=9UgmXd4v3TIc9n4xsYN8gLYWH_H3YoFK6twdNr3syaA&e=> > > > ------------------------------ > > To unsubscribe from the CCP4BB list, click the following link: > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > <https://urldefense.proofpoint.com/v2/url?u=https-3A__www.jiscmail.ac.uk_cgi-2Dbin_webadmin-3FSUBED1-3DCCP4BB-26A-3D1&d=DwMFaQ&c=Dbf9zoswcQ-CRvvI7VX5j3HvibIuT3ZiarcKl5qtMPo&r=HK-CY_tL8CLLA93vdywyu3qI70R4H8oHzZyRHMQu1AQ&m=32JRE8HZHPdJxpaoz1sLz-PnTi-D_zZTMfdQs_FdEcI&s=9UgmXd4v3TIc9n4xsYN8gLYWH_H3YoFK6twdNr3syaA&e=> > > ------------------------------ > > To unsubscribe from the CCP4BB list, click the following link: > https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1 > ######################################################################## To unsubscribe from the CCP4BB list, click the following link: https://www.jiscmail.ac.uk/cgi-bin/webadmin?SUBED1=CCP4BB&A=1
